Beneficence or maleficence - Big tobacco and smokeless products

Addiction

Volumn 104, Issue 2, 2009, Pages 167-168

  McNeill, Ann ^a   Sweanor, David ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Industry; Nicotine; Products; Regulation; Smokeless; Tobacco

Indexed keywords

BENEFICENCE; CIGARETTE SMOKING; EDITORIAL; HARM REDUCTION; MALEFICENCE; SMOKELESS TOBACCO; SMOKING CESSATION; SOCIAL BEHAVIOR;

CONSUMER ORGANIZATIONS; HUMANS; LOBELINE; MARKETING; TOBACCO INDUSTRY;

EID: 58349089718     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2008.02483.x     Document Type: Editorial

References (7)

1. Chapman S. Repealing Australia's ban on smokeless tobacco? Hasten slowly. Med J Aust 2008 188 : 47 9.
2. Gartner C. E., Hall W. D., Vos T., Bertram M. Y., Wallace A. L. et al. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet 369 : 2010 4.
3. Royal College of Physicians (RCP) Tobacco Advisory Group. Harm Reduction in Nicotine Addiction. Helping People Who Can't Quit. London : RCP 2007.
4. Foulds J., Furberg H. Is low-nicotine Marlboro snus really snus? Harm Reduct J 2008 5 : 9. Available from http://www.harmreductionjournal.com.
5. Shiffman S., Gitchell J. G., Rohay J. M., Hellebusch S. J., Kemper K. E. Smokers' preferences for medicinal nicotine vs smokeless tobacco. Am J Health Behav 2007 31 : 463 72.
6. Mortimer K., Borland R., McNeill A. An exploratory study of the acceptability of less harmful alternatives to cigarettes among current smokers. Poster. SRNT Europe Conference, Rome, Italy, September 2008.
7. Commission of the European Communities. Report from the Commission to the European Parliament, the Council and the European Economic and Social Committee. Second Report on the Application of the Tobacco Products Directive. Brussels, November 2007.